Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Open in API
Filings indexed 965 across all filing types
Latest filing 2015-05-06 Transaction in Own Shar…
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
Medivir’s board of directors has resolved to repurchase own shares
Transaction in Own Shares Classification · 99% confidence The document explicitly states that the board of directors has resolved to repurchase its own shares ('Medivir's board of directors has resolved to repurchase own shares'). It details the maximum number of shares, the purpose (capital distribution, capital structure), and the conditions for the buyback. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases.
2015-05-06 English
Medivirs styrelse har beslutat om återköp av egna aktier
Transaction in Own Shares Classification · 99% confidence The document text is a formal announcement from Medivir AB stating that its board has decided to repurchase its own B-shares ('återköp av egna aktier'). It details the purpose (capital distribution, capital structure optimization), the maximum number of shares (2,696,603), and the regulatory context for the buyback. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing type code for this activity is POS.
2015-05-06 Swedish
Resolutions at the annual general meeting in Medivir on 5 May 2015
AGM Information Classification · 98% confidence The document explicitly details the 'Resolutions at the annual general meeting in Medivir on 5 May 2015'. It covers the election of the board, remuneration decisions, authorizations for share issuance/repurchase, and the approval of financial statements, which are all typical outcomes of an AGM. Since the document lists the resolutions passed at the meeting itself, it aligns best with the 'AGM Information' category, which covers presentations and materials shared during the AGM.
2015-05-05 English
Beslut vid årsstämma i Medivir den 5 maj 2015
AGM Information Classification · 99% confidence The document is titled "Beslut vid årsstämma i Medivir den 5 maj 2015" (Decisions at the Annual General Meeting in Medivir on May 5, 2015). It details resolutions passed regarding the election of the board and auditor, remuneration, guidelines for executive compensation, authorization for share issuance and buybacks, and the approval of 2014 financial statements. These topics are central to the proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2015-05-05 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Medivir AB covering the period January-March 2015. It contains detailed financial statements, including income statements, balance sheets, cash flow analysis, and management commentary on business performance, R&D projects, and market outlook. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2015
2015-05-05 Swedish
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY – MARCH 2015' and contains detailed financial statements, including income statements, cash flow analysis, and management commentary on business performance for the first quarter. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2015
2015-05-05 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.